Clinical Trials Logo

Infant, Newborn clinical trials

View clinical trials related to Infant, Newborn.

Filter by:

NCT ID: NCT01029353 Completed - Infant, Premature Clinical Trials

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

NEST
Start date: January 2010
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of two surgical procedures -laparotomy versus drainage - commonly used to treat necrotizing enterocolitis (NEC) or isolated intestinal perforations (IP) in extremely low birth weight infants (≤1,000 g). Infants diagnosed with NEC or IP requiring surgical intervention, will be recruited. Subjects will be randomized to receive either a laparotomy or peritoneal drainage. Primary outcome is impairment-free survival at 18-22 months corrected age.

NCT ID: NCT00882284 Completed - Blood Pressure Clinical Trials

Hypotension in Neonates

Start date: April 2009
Phase:
Study type: Observational

This observational study collects information on the current incidence and management of hypotension in babies born at term or late preterm that are admitted to Neonatal Intensive Care Units (NICUs) within the Neonatal Research Network (NRN). Participants include all newborn infants born at 34 0/7 weeks gestation or greater who are admitted to NICU Network centers and intubated and mechanically ventilated at less than 72 hours of age. The information gathered will provide a framework for the design of a potential randomized controlled trial for the treatment of hypotension in neonates. This observational study is for a time-limited enrollment period of 4-6 months; NRN centers will continue to enroll until at least 50 patients are enrolled per center (for approximately 800-1,000 subjects total).

NCT ID: NCT00874393 Completed - Blood Pressure Clinical Trials

Early Blood Pressure Management in Extremely Premature Infants

ELGAN BP
Start date: July 2009
Phase: Phase 1
Study type: Interventional

This trial tests the feasibility of enrolling 60 extremely preterm infants in a randomized, double-blinded study of blood pressure management within 12 months. Eligible infants will receive an infusion drug (dopamine or a dextrose placebo) and a syringe drug (hydrocortisone or a normal saline placebo). Enrolled infants will be randomized to receive one of the following drug pairs: - dopamine and hydrocortisone - dopamine and normal saline - dextrose and hydrocortisone - dextrose and normal saline. In addition to the intervention above, the NRN is conducting a 6-month time-limited prospective observational study of all infants born at an NRN center between 23 and 26 weeks gestational age. All clinical decisions made for these babies will be at the discretion of the attending neonatologist/infant care team according to standard practice at each institution. Data on blood pressure management in the first 24 postnatal hours collected for each infant.

NCT ID: NCT00874367 Completed - Sepsis Clinical Trials

Early-Onset Sepsis Surveillance Study

EOS
Start date: February 2006
Phase: N/A
Study type: Observational

In this observational study, the NICHD Neonatal Research Network (NRN) is conducting surveillance of all infants born at NRN centers to identify all newborns who are diagnosed with early-onset sepsis (EOS) and/or meningitis. The study will: establish current hospital-based rates of EOS among term and preterm infants in the era of intrapartum antibiotic prophylaxis; monitor the organisms associated with EOS and meningitis; compare asymptomatic and symptomatic infants by gestational age and pathogen; and monitor sepsis-associated mortality rates by pathogen group.

NCT ID: NCT00873847 Completed - Infant, Premature Clinical Trials

Cerebral Function Monitoring in Premature Infants

Start date: July 2009
Phase: N/A
Study type: Observational

This observational study tests the feasibility of enrolling subjects and obtaining an amplitude-integrated electroencephalogram (aEEG) within the first 72 hours of life, a second aEEG recording between 72-168 hours of life, and weekly thereafter up to 36 weeks post-menstrual age. It will enroll 85-100 infants between 401-1,000 grams birth weight OR between 23 0/7 and 28 6/7 weeks gestational age born at the 7 participating NICHD Neonatal Research Network sites.

NCT ID: NCT00820677 Completed - Infant, Newborn Clinical Trials

Newborn Health Information Study

Start date: November 2008
Phase: N/A
Study type: Interventional

This is a randomized, controlled trial to test the use of an educational video during the newborn well-child visit. Parents who watch the video during their medical visit will be compared to those parents who receive traditional paper handouts. Measures obtained at baseline and 2-week follow-up include knowledge of infant development, self-efficacy with infant care, and problem-solving skills.

NCT ID: NCT00798382 Completed - Infant, Newborn Clinical Trials

Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants

Start date: December 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.

NCT ID: NCT00716781 Completed - Sepsis Clinical Trials

Management of Infants Born to Group B Streptococcus Positive Mothers.

Start date: July 2004
Phase: N/A
Study type: Observational

Intrapartum antibiotic prophylaxis has greatly decreased but not abolished early-onset neonatal sepsis caused by GBS. According to current recommendations, the evaluation of infants at risk for GBS sepsis should include a complete blood count (CBC), WBC differential, a blood culture (BC) and a period of observation. The usefulness of CBC and BC in the evaluation process is not firmly established.

NCT ID: NCT00705562 Completed - Infant, Newborn Clinical Trials

Tolerance of Healthy Term Infants Fed Infant Formulas

Start date: June 2008
Phase: Phase 2
Study type: Interventional

The objective of the study is to assess comparative gastrointestinal tolerance of normal term infants to various milk-protein infant formulas.

NCT ID: NCT00614744 Completed - Infant, Newborn Clinical Trials

Late Hypothermia for Hypoxic-Ischemic Encephalopathy

Start date: April 2008
Phase: N/A
Study type: Interventional

This study is a randomized, placebo-controlled, clinical trial to evaluate whether induced whole-body hypothermia initiated between 6-24 hours of age and continued for 96 hours in infants ≥ 36 weeks gestational age with hypoxic-ischemic encephalopathy will reduce the incidence of death or disability at 18-22 months of age. The study will enroll 168 infants with signs of hypoxic-ischemic encephalopathy at 16 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.